Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs

Exclusion Criteria

• •1. Any corneal abnormality, other than regular corneal astigmatism (as determined by pre-operative testing) that in the opinion of the investigator would confound the outcome(s) of the study
• •2. Any complication during cataract surgery (capsular tear, vitrectomy, etc)
• •3. History of or current retinal conditions in either eye that would confound the results of this investigation in the opinion of the investigator (e.g. retinal detachment, epiretinal membrane, retinal ischemia, retinal inflammation, etc)
• •4. Amblyopia or strabismus in either eye
• •5. History of or current anterior or posterior segment inflammation of any etiology
• •6. Any form of neovascularization on or within the eye
• •7. Glaucoma (uncontrolled or controlled with medication)
• •8. Optic nerve atrophy
• •9. Subjects with diagnosed degenerative eye disorders
• •10. Postoperative CDVA worse than 0.10 logMAR (20/25 snellen) in either eye.
• •11. Subjects who have an acute or chronic disease or illness that would confound the results of this investigation in the opinion of the investigator (e.g. immunocompromised, connective tissue disease, clinically significant atopic disease, etc)